The use of radiation therapy for oligoprogressive/oligopersistent oncogene-driven non small cell lung cancer: State of the art-Reference-Cited by-同舟云学术

The use of radiation therapy for oligoprogressive/oligopersistent oncogene-driven non small cell lung cancer: State of the art

Published:2020-04 Issue: Volume:148 Page:102894
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Franceschini D.^ORCID,De Rose F.,Cozzi S.,Franzese C.,Rossi S.^ORCID,Finocchiaro G.,Toschi L.,Santoro A.,Scorsetti M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference57 articles.

1. Pattern of failure analysis in metastatic EGFR-mutant lung cancer treated with tyrosine kinase inhibitors to identify candidates for consolidation stereotactic body radiation therapy;Al-Halabi;J. Thorac. Oncol.,2015

2. The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer;Arrieta;Lung Cancer,2015

3. The safety of afatinib for the treatment of non-small cell lung cancer;Barron;Expert Opin. Drug Saf.,2016

4. Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an EGFR mutation;Barrón;J. Thorac. Dis.,2018

5. Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group;Borghetti;Radiol. Med.,2019

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lokaltherapie im Stadium IV bei Oligopersistenz oder Progression;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2024-08

2. Radiosurgery in Grade II and III Meningiomas: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2024-07-29

3. Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC;Expert Review of Anticancer Therapy;2024-04-21

4. Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer;International Journal of Molecular Sciences;2024-04-20

5. Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?;Exploration of Targeted Anti-tumor Therapy;2023-12-13